Black Diamond Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/05/22
Black Diamond Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 11/08/21
Black Diamond Therapeutics Presents Preclinical Data on BDTX-1535, BRAF, and FGFR Programs at the 33rd AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsGlobeNewsWire • 10/08/21
Black Diamond Therapeutics to Present Pre-Clinical Data on BDTX-1535, BRAF, and FGFR Programs at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsGlobeNewsWire • 09/30/21
Black Diamond Therapeutics to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare ConferenceGlobeNewsWire • 09/21/21
Black Diamond Therapeutics and OpenEye Scientific Announce Collaboration to Expand MAP Drug Discovery PlatformGlobeNewsWire • 09/21/21
Black Diamond Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 08/12/21
Black Diamond Therapeutics Announces Appointment of Mark Velleca, M.D., Ph.D. to Board of DirectorsGlobeNewsWire • 08/10/21
Black Diamond Therapeutics Stock Plunges On Safety Signals In Solid Tumor Study Of BDTX-189Benzinga • 05/20/21
Black Diamond Therapeutics Presents Phase 1 Pharmacokinetic, Safety, and Preliminary Efficacy Data of BDTX-189 in Advanced Solid Tumors Harboring EGFR or HER2 AlterationsGlobeNewsWire • 05/19/21
Black Diamond Therapeutics to Host Webcast Presentation of Data From Phase 1 Dose-Escalation Portion of MasterKey-01 Clinical TrialGlobeNewsWire • 05/17/21
Black Diamond Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/07/21
Black Diamond Therapeutics to Present Phase 1 BDTX-189 Data in Advanced Solid Tumors at American Society of Clinical OncologyGlobeNewsWire • 04/28/21
Black Diamond Therapeutics Announces Preclinical Data Presentations on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual MeetingGlobeNewsWire • 04/10/21
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate UpdateGlobeNewsWire • 03/25/21
Black Diamond Therapeutics to Present Pre-Clinical Data on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual MeetingGlobeNewsWire • 03/10/21
Black Diamond Therapeutics Announces Pre-Clinical Data Presentations on New Programs Targeting BRAF and FGFR at ESMO TAT Virtual Congress 2021GlobeNewsWire • 03/02/21
Black Diamond Therapeutics Announces Appointment of Oncology Clinical Development Veteran Dr. Kapil Dhingra to Board of DirectorsGlobeNewsWire • 01/20/21
Black Diamond Therapeutics to Present at the J.P. Morgan 39th Annual Healthcare ConferenceGlobeNewsWire • 01/05/21
Black Diamond Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare ConferenceGlobeNewsWire • 11/24/20
Black Diamond Therapeutics Provides Update on GBM Program and Presents Pre-Clinical Data at the 2020 SNO Annual MeetingGlobeNewsWire • 11/20/20
Black Diamond Therapeutics to Present at the Jefferies 2020 Virtual London Healthcare ConferenceGlobeNewsWire • 11/11/20